Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $1.16 Million - $1.33 Million
-44,904 Reduced 48.43%
47,821 $1.33 Million
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $463,938 - $602,604
17,755 Added 23.68%
92,725 $2.67 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $113,887 - $133,122
3,549 Added 4.97%
74,970 $2.49 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $2.76 Million - $3.19 Million
-76,275 Reduced 51.64%
71,421 $2.62 Million
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $2 Million - $2.6 Million
-50,784 Reduced 25.59%
147,696 $6.03 Million
Q4 2022

Jan 31, 2023

BUY
$41.75 - $54.5 $1.61 Million - $2.1 Million
38,517 Added 24.08%
198,480 $10.2 Million
Q3 2022

Oct 26, 2022

SELL
$43.76 - $53.42 $5.63 Million - $6.87 Million
-128,669 Reduced 44.58%
159,963 $7 Million
Q2 2022

Oct 26, 2022

BUY
$46.53 - $55.17 $9.38 Million - $11.1 Million
201,556 Added 231.47%
288,632 $15.1 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $13.4 Million - $15.9 Million
288,632 New
288,632 $15.1 Million
Q1 2022

Oct 26, 2022

SELL
$45.75 - $56.69 $9.22 Million - $11.4 Million
-201,556 Reduced 69.83%
87,076 $4.51 Million
Q4 2021

Oct 26, 2022

SELL
$41.32 - $61.25 $10.1 Million - $14.9 Million
-244,075 Reduced 84.56%
44,557 $2.63 Million
Q4 2021

Feb 02, 2022

SELL
$41.32 - $61.25 $1.25 Million - $1.86 Million
-30,303 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $666,818 - $856,585
16,989 Added 127.6%
30,303 $1.3 Million
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $82,162 - $93,075
2,288 Added 20.75%
13,314 $521,000
Q1 2021

May 10, 2021

BUY
$33.49 - $37.77 $29,772 - $33,577
889 Added 8.77%
11,026 $399,000
Q4 2020

Feb 08, 2021

BUY
$33.47 - $42.56 $18,006 - $22,897
538 Added 5.6%
10,137 $373,000
Q3 2020

Nov 02, 2020

BUY
$31.75 - $37.25 $100,012 - $117,337
3,150 Added 48.84%
9,599 $352,000
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $53,824 - $65,296
1,787 Added 38.33%
6,449 $211,000
Q1 2020

May 18, 2020

BUY
$27.03 - $38.62 $4,676 - $6,681
173 Added 3.85%
4,662 $152,000
Q4 2019

Sep 02, 2020

BUY
$32.92 - $37.36 $2,929 - $3,325
89 Added 2.02%
4,489 $176,000
Q3 2019

Nov 15, 2019

BUY
$32.49 - $42.13 $74,824 - $97,025
2,303 Added 109.82%
4,400 $158,000
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $81,984 - $92,049
-2,217 Reduced 51.39%
2,097 $91,000
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $134,645 - $153,510
3,500 Added 429.98%
4,314 $188,000
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $28,058 - $34,033
814 New
814 $36,000
Q1 2018

May 16, 2018

SELL
$31.91 - $37.02 $302,762 - $351,245
-9,488 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $4,689 - $4,975
141 Added 1.51%
9,488 $344,000
Q3 2017

Nov 15, 2017

BUY
$31.0 - $34.15 $289,757 - $319,200
9,347
9,347 $334,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Balentine LLC Portfolio

Follow Balentine LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.